Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform

Journal of Clinical Hypertension

Volumn 10, Issue 4, 2008, Pages 295-303

  Nichols, Wilmer W ^a   Denardo, Scott J ^a   Wilkinson, Ian B ^b   McEniery, Carmel M ^b   Cockcroft, John ^c   O'Rourke, Michael F ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VASODILATOR AGENT;

AORTA; ARTERY; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; ELASTICITY; HUMAN; PATHOPHYSIOLOGY; PULSE RATE; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULAR RESISTANCE;

AORTA; ARTERIES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ELASTICITY; HUMANS; PULSE; RISK ASSESSMENT; RISK FACTORS; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 46349106826     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.04746.x     Document Type: Review

References (52)

1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
2. Haider AW, Larson MG, Franklin SS, et al. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138(1):10-16.
3. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
4. Chirinos JA, Zambrano JP, Chakko S, et al. Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol. 2005;96(5):645-648.
5. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles. 5th ed. London, England: Edward Arnold; 2005.
6. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932-937.
7. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure. The Strong Heart Study. Hypertension. 2007;50(1):197-203.
8. McEniery CM, Yasmin, Hall IR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46(9):1753-1760.
9. Wallace SM, Yasmin, McEniery CM, et al. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension. 2007;50(1):228-233.
10. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109(2):184-189.
11. Hirai T, Sasayama S, Kawasaki T, et al. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989;80(1):78-86.
12. Weber T, Auer J, Lamm G, et al. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification. J Card Fail. 2007;13(5):353-359.
13. London GM, Marchais SJ, Guerin AP. Arterial stiffness and function in end-stage renal disease. Adv Chronic Kidney Dis. 2004;11(2):202-209.
14. Wilkinson IB, MacCallum H, Rooijmans DF, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93(7):441-448.
15. Brooks BA, Molyneaux LM, Yue DK. Augmentation of central arterial pressure in Type 2 diabetes. Diabet Med. 2001;18(5):374-380.
16. Wilkinson IB, Prasad K, Hall IR, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002;39(6):1005-1011.
17. Tayama J, Munakata M, Yoshinaga K, et al. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens Res. 2006;29(6):403-409.
18. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005;18(1):50-55.
19. Maki-Petaja KM, Booth AD, Hall FC, et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007;50(9):852-858.
20. Kullo IJ, Seward JB, Bailey KR, et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens. 2005;18(8):1123-1129.
21. Phillips C, Hedner J, Berend N, et al. Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep. 2005;28(5):604-609.
22. Sato E, Feke GT, Appelbaum EY, et al. Association between systemic arterial stiffness and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2006;244(8):963-971.
23. Wilkinson IB, Franklin SS, Hall IR, et al. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension. 2001;38(6):1461-1466.
24. Boutouyrie P, Bussy C, Lacolley P, et al. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation. 1999;100(13):1387-1393.
25. Nakayama Y, Tsumura K, Yamashita N, et al. Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty. Circulation. 2000;101(5):470-472.
26. Jankowski P, Kawecka-Jaszcz K, Czarnecka D, et al. Ascending aortic, but not brachial blood pressurederived indices are related to coronary atherosclerosis. Atherosclerosis. 2004;176(1):151-155.
27. Hashimoto J, Imai Y, O'Rourke MF. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am J Hypertens. 2007;20(4):378-384.
28. Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J. 2000;140(6):848-856.
29. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39(3):735-738.
30. O'Rourke MF, Kelly RP, Avolio AP, et al. Effects of arterial dilator agents on central aortic systolic pressure and on left ventricular hydraulic load. Am J Cardiol. 1989;63(19):38I-44I.
31. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113(9):1213-1225.
32. McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clin Exp Pharmacol Physiol. 2007;34(7):665-671.
33. Mitchell GF, Parise H, Benjamin EJ, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004;43(6):1239-1245.
34. Westerhof N, Sipkema P, van den Bos GC, et al. Forward and backward waves in the arterial system. Cardiovasc Res. 1972;6(6):648-656.
35. Murgo JP, Westerhof N, Giolma JP, et al. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation. 1980;62(1):105-116.
36. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561-1566.
37. Westerhof N, O'Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13(9):943-952.
38. Papaioannou TG, Karatzis EN, Papamichael CM, et al. Circadian variation of arterial pressure wave reflections. Am J Hypertens. 2006;19(3):259-263.
39. Jatoi NA, Jerrard-Dunne P, Feely J, et al. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension. 2007;49(5):981-985.
40. Vlachopoulos C, Panagiotakos D, Ioakeimidis N, et al. Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections. Am J Clin Nutr. 2005;81(6):1307-1312.
41. Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007;20(4):392-397.
42. Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension. Hypertension. 2003;41(2):297-301.
43. Tropeano AI, Boutouyrie P, Pannier B, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension. 2006;48(1):80-86.
44. Asmar RG, London GM, O'Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001;38(4):922-926.
45. Morgan T, Lauri J, Bertram D, et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17(2):118-123.
46. Levenson J, Gariepy J, Megnien JL, et al. Diuretics and arteriolar resistance and arterial compliance in human hypertension. Eur Heart J. 1992;13 suppl G:48-52.
47. de Luca N, Asmar RG, London GM, et al; REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22(8):1623-1630.
48. Devereux RB, Dahlof B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation. 2004;110(11):1456-1462. Epub 2004 Aug 23.
49. Mathew J, Sleight P, Lonn E, et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001;104(14):1615-1621.
50. Kass DA, Shapiro EP, Kawaguchi M, et al. Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104(13):1464-1470.
51. Ariyoshi T, Eishi K, Sakamoto I, et al. Effect of etidronic acid on arterial calcification in dialysis patients. Clin Drug Investig. 2006;26(4):215-222.
52. Hope SA, Tay DB, Meredith IT, et al. Waveform dispersion, not reflection, may be the major determinant of aortic pressure wave morphology. Am J Physiol Heart Circ Physiol. 2005;289(6):H2497-H2502.